drugset / Trial / NCT03448536

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

NCT03448536

Phase 4 Completed 201 enrolled Bayer
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the maximum single dose of Aleve® (two tablets, equivalent to 440 mg of naproxen sodium) to the maximum single dose of Tylenol Extra Strength (two caplets, equivalent to 1000 mg of acetaminophen) in the treatment of menstrual pain associated with primary dysmenorrhea.

Timeline

Start
2018-04-05
Primary completion
2018-09-05
Completion
2018-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg Oral
Subject Naproxen Small molecule 440 mg Oral

Indications